APA (7th ed.) Citation

Tanaka, Y., Kondo, K., Ichibori, A., Yanai, Y., Susuta, Y., Inoue, S., & Takeuchi, T. (2020). Amiselimod, a sphingosine 1-phosphate receptor-1 modulator, for systemic lupus erythematosus: A multicenter, open-label exploratory study. Lupus, 29(14), 1902-1913. https://doi.org/10.1177/0961203320966385

Chicago Style (17th ed.) Citation

Tanaka, Yoshiya, Kazuoki Kondo, Ayako Ichibori, Yoshiari Yanai, Yutaka Susuta, Shinsuke Inoue, and Tsutomu Takeuchi. "Amiselimod, a Sphingosine 1-phosphate Receptor-1 Modulator, for Systemic Lupus Erythematosus: A Multicenter, Open-label Exploratory Study." Lupus 29, no. 14 (2020): 1902-1913. https://doi.org/10.1177/0961203320966385.

MLA (9th ed.) Citation

Tanaka, Yoshiya, et al. "Amiselimod, a Sphingosine 1-phosphate Receptor-1 Modulator, for Systemic Lupus Erythematosus: A Multicenter, Open-label Exploratory Study." Lupus, vol. 29, no. 14, 2020, pp. 1902-1913, https://doi.org/10.1177/0961203320966385.